Contents

Current Pharmaceutical Design, Volume 18 - Number 20

Editorial [Hot Topic: Protein Kinase Inhibitors: Current Strategies and Future Prospects (Executive Guest Editor: Julio Caballero)]

, 18(20): 2851

Julio Caballero


DOI: 10.2174/138161212800672769




Conformationally Constrained Peptides as Protein Tyrosine Kinase Inhibitors

, 18(20): 2852 - 2866

Rakesh K. Tiwari and Keykavous Parang


DOI: 10.2174/138161212800672714




Radiolabeled Small Molecule Inhibitors of VEGFR - Recent Advances

, 18(20): 2867 - 2874

Torsten Kniess


DOI: 10.2174/138161212800672796




Recent Advances in Designing Substrate-Competitive Protein Kinase Inhibitors

, 18(20): 2875 - 2882

Ki-Cheol Han, So Yeon Kim and Eun Gyeong Yang


DOI: 10.2174/138161212800672697




Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target

, 18(20): 2883 - 2890

Vladimir Krystof, Sonja Baumli and Robert Furst


DOI: 10.2174/138161212800672750




Kinase Inhibitor Conjugates

, 18(20): 2891 - 2900

Stefan Harmsen and Robbert Jan Kok


DOI: 10.2174/138161212800672778




Insulin-like Growth Factor-1 Receptor (IGF-1R) Kinase Inhibitors in Cancer Therapy: Advances and Perspectives

, 18(20): 2901 - 2913

Mengzhu Xue, Xianwen Cao, Ye Zhong, Dong Kuang, Xiaofeng Liu, Zhenjiang Zhao and Honglin Li


DOI: 10.2174/138161212800672723




Exploiting Substrate Recognition for Selective Inhibition of Protein Kinases

, 18(20): 2914 - 2920

Avital Licht-Murava and Hagit Eldar-Finkelman


DOI: 10.2174/138161212800672741




Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials

, 18(20): 2921 - 2935

Cunlong Zhang, Chunyan Tan, Huaiwei Ding, Tian Xin and Yuyang Jiang


DOI: 10.2174/138161212800672732




New Directions in Targeting Protein Kinases: Focusing Upon True Allosteric and Bivalent Inhibitors

, 18(20): 2936 - 2945

Vandana Lamba and Indraneel Ghosh


DOI: 10.2174/138161212800672813




Molecular Dynamics of Protein Kinase-Inhibitor Complexes: A Valid Structural Information

, 18(20): 2946 - 2963

Julio Caballero and Jans H. Alzate-Morales


DOI: 10.2174/138161212800672705




Rho Kinase Inhibitors: Potential Treatments for Diabetes and Diabetic Complications

, 18(20): 2964 - 2973

Hong Zhou and Yong-jun Li


DOI: 10.2174/138161212800672688




Cyclin-dependent kinase Inhibitors Inspired by Roscovitine: Purine Bioisosteres

, 18(20): 2974 - 2980

Radek Jorda, Kamil Paruch and Vladimir Krystof


DOI: 10.2174/138161212800672804




Recent Advances in Thymidine Kinase 2 (TK2) Inhibitors and New Perspectives for Potential Applications

, 18(20): 2981 - 2994

Eva-Maria Priego, Anna Karlsson, Federico Gago, Maria-Jose Camarasa, Jan Balzarini and Maria-Jesus Perez-Perez


DOI: 10.2174/138161212800672787




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science